Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Prices €1.7 Billion Offering of Senior Notes

NEW YORK – Danaher announced Wednesday that it has priced its offering of €1.7 billion ($1.9 billion) senior notes.

The offering consists of €750 million principal amount of 1.7 percent senior notes due 2024; €500 million principal amount of 2.1 percent senior notes due 2026; and €500 million principal amount of 2.5 percent senior notes due 2030.

The Washington, DC-based conglomerate said it expects to use the funds for general corporate purposes, potentially including repaying some of its outstanding commercial paper borrowings or repayment of amounts borrowed under its five-year revolving credit facility. 

The offering is expected to close March 30.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.